Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
72.4 CHF | +0.42% | +1.40% | +42.24% |
Apr. 25 | Cosmo Pharmaceuticals Names New CEO, Chairman | MT |
Mar. 20 | Transcript : Cosmo Pharmaceuticals N.V. - Analyst/Investor Day |
Sales 2023 | 96.72M 104M 94.63M | Sales 2024 * | 262M 281M 256M | Capitalization | 1.18B 1.27B 1.16B |
---|---|---|---|---|---|
Net income 2023 | 1M 1.07M 978K | Net income 2024 * | 111M 119M 109M | EV / Sales 2023 | 8.6 x |
Net cash position 2023 | 48.44M 52.04M 47.39M | Net cash position 2024 * | 110M 118M 108M | EV / Sales 2024 * | 4.1 x |
P/E ratio 2023 |
771
x | P/E ratio 2024 * |
10.1
x | Employees | 319 |
Yield 2023 |
3.65% | Yield 2024 * |
2.85% | Free-Float | 44.49% |
Latest transcript on Cosmo Pharmaceuticals N.V.
1 day | -0.35% | ||
1 week | +1.40% | ||
Current month | +1.54% | ||
1 month | +11.38% | ||
3 months | +15.84% | ||
6 months | +113.88% | ||
Current year | +42.24% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 61 | 05-12-31 | |
Niall Donnelly
DFI | Director of Finance/CFO | 52 | 16-05-31 |
Chief Tech/Sci/R&D Officer | 54 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
David W Maris
BRD | Director/Board Member | 57 | 21-05-27 |
Founder | 69 | 96-12-31 | |
Director/Board Member | 64 | 05-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 10 M€ | -3.35% | - | |
0.00% | 773 M€ | -.--% | - | |
0.00% | 34 M€ | +2.22% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 72.4 | +0.42% | 225 |
24-04-25 | 72.1 | -4.25% | 14,274 |
24-04-24 | 75.3 | +1.21% | 17,185 |
24-04-23 | 74.4 | +1.36% | 26,912 |
24-04-22 | 73.4 | +2.80% | 21,855 |
Delayed Quote Swiss Exchange, April 26, 2024 at 04:05 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+42.24% | 1.27B | |
+24.81% | 556B | |
-6.33% | 354B | |
+19.90% | 331B | |
+7.95% | 296B | |
+12.92% | 233B | |
+5.43% | 201B | |
-10.02% | 193B | |
-12.26% | 143B | |
-6.47% | 144B |
- Stock Market
- Equities
- COPN Stock